Parametric Portfolio Associates’s CareDx CDNA Stock Holding History

Parametric Portfolio Associates’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$2.93M	Buy	79,209 +8,890	+13%	+$346K	﹤0.01%	2203
2021 Q4	$3.2M	Sell	70,319 -8,237	-10%	-$430K	﹤0.01%	2153
2021 Q3	$4.98M	Buy	78,556 +8,973	+13%	+$683K	﹤0.01%	1828
2021 Q2	$6.37M	Buy	69,583 +5,963	+9%	+$474K	﹤0.01%	1692
2021 Q1	$4.33M	Sell	63,620 -7,387	-10%	-$574K	﹤0.01%	2280
2020 Q4	$5.14M	Buy	71,007 +27,941	+65%	+$1.62M	﹤0.01%	2056
2020 Q3	$1.63M	Buy	43,066 +3,255	+8%	+$110K	﹤0.01%	2632
2020 Q2	$1.41M	Sell	39,811 -2,948	-7%	-$83.9K	﹤0.01%	2719
2020 Q1	$933K	Buy	42,759 +12,329	+41%	+$276K	﹤0.01%	2832
2019 Q4	$656K	Buy	30,430 +1,240	+4%	+$28.4K	﹤0.01%	3266
2019 Q3	$660K	Sell	29,190 -21,067	-42%	-$583K	﹤0.01%	3235
2019 Q2	$1.81M	Buy	50,257 +456	+0.9%	+$14.6K	﹤0.01%	2732
2019 Q1	$1.57M	Sell	49,801 -50,975	-51%	-$1.49M	﹤0.01%	2788
2018 Q4	$2.53M	Buy	100,776 +25,784	+34%	+$662K	﹤0.01%	2421
2018 Q3	$2.16M	Buy	74,992 +29,072	+63%	+$544K	﹤0.01%	2658
2018 Q2	$562K	Buy	+45,920	New	+$527K	﹤0.01%	3299

Other funds holding CDNA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

Parametric Portfolio Associates's CDNA Position: Q1 2022 in Review

Parametric Portfolio Associates increased its CareDx (CDNA) stake by 13% in Q1 2022, buying an estimated $346K and bringing the position to 79,209 shares worth $2.93M. The position accounts for ﹤0.01% of the portfolio, ranked #2203.

Parametric Portfolio Associates first reported a position in CDNA in Q2 2018 and has held it in 16 quarters since. The position peaked at $6.37M in Q2 2021. 213 funds tracked by Wall St. Rank hold CDNA as of Q1 2022.

Parametric Portfolio Associates held 79,209 shares of CareDx worth $2.93M as of Q1 2022.
Parametric Portfolio Associates bought 8,890 CareDx shares in Q1 2022, an estimated $346K.
CareDx made up ﹤0.01% of Parametric Portfolio Associates's portfolio in Q1 2022, its #2203 holding.
Parametric Portfolio Associates first reported a position in CareDx in Q2 2018 and has held it in 16 quarters since.
Parametric Portfolio Associates's CareDx position peaked at $6.37M in Q2 2021.
213 funds tracked by Wall St. Rank held CareDx as of Q1 2022.

Based on Parametric Portfolio Associates's 13F filing for Q1 2022, filed 16 May 2022.